(Q42931701)

11 November 2017

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations (English)

1 reference

11 November 2017

6

A Tefferi

1 reference

11 November 2017

A Pardanani

1

1 reference

11 November 2017

T Lasho

2

1 reference

11 November 2017

C Finke

3

1 reference

11 November 2017

S T Oh

4

1 reference

11 November 2017

J Gotlib

5

1 reference

11 November 2017

19 August 2010

1 reference

11 November 2017

1 reference

11 November 2017

24

1 reference

11 November 2017

10

1 reference

11 November 2017

1713-1718

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.163

11 November 2017

0 references

cites work

JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Lnk constrains myeloproliferative diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

inferred from DOI database lookup

7 January 2021

based on heuristic

Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

inferred from DOI database lookup

7 January 2021

based on heuristic

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.163

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.163

1 reference

Dimensions Publication ID

11 November 2017

0 references

1 reference